In this group, the pooled HR of 33 studies showed that high survivin expression levels were associated with reduced overall survival in lung cancer patients (HR 2.00; 95% CI: 1.61–2.47; p < 0.00001) (Figure 3A). Here, BIRC5 is linked to lung carcinoma.